Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIS-guided target-controlled infusion of ciprofol versus propofol in radical oral cancer surgery
ChiCTR2300075443Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Sep 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and propofol in mouth cancer (4 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Success rate of anesthesia induction. Started Sep 2022; status: completed.
02
Drugs
ciprofolpropofol
03
Conditions
mouth cancer
Beyond the preview
Go deeper on ChiCTR2300075443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075443.